Sensei Bio
Christopher Gerry, J.D., is a life science attorney with experience in operations, business development, and strategy. Prior to joining Sensei in July 2022, Mr. Gerry served as VP, Deputy General Counsel at AVROBIO, where he was responsible for SEC reporting and public company affairs, financings, corporate governance, business development, and various other legal matters. Previously, Mr. Gerry was an associate at Cooley LLP, where he represented life sciences companies in a wide variety of matters through all stages of their life cycle, from initial formation through venture financings, initial public offerings, follow-on offerings, and exit events. He holds a B.A. from Dickinson College and earned his J.D. from Boston University School of Law.
This person is not in any offices
Sensei Bio
Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.